EUVIMEDEUVIMED entdecken
Crossref

Astaxanthin ameliorates cisplatin‐induced damage in normal human fibroblasts

Momoho Yamaguchi, Kei Tomihara, Wataru Heshiki, Kotaro Sakurai, Katsuhisa Sekido, Hidetake Tachinami, Rohan Moniruzzaman, Sayaka Inoue, Kumiko Fujiwara, Makoto Noguchi

Oral Science International · 2019-12 · 16 (3) · 171-177

DOI: 10.1002/osi2.1031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Science International, online erschienen am 12.09.2019. Verfasst von Momoho Yamaguchi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oral mucositis is a common adverse side effect of cancer chemotherapy. Its management is of vital importance during cancer treatment. Oxidative stress against normal cells, including epithelial and stromal cells, has been implicated in the pathogenesis of chemotherapy‐induced oral mucositis. Fibroblasts may play a major role in the repair of oral mucosal tissue after chemotherapy. Astaxanthin (AST), a natural xanthophyll carotenoid, has sparked interest because of its strong antioxidant and anti‐inflammatory properties. This study illustrates the protective effects of astaxanthin on normal fibroblasts damaged by chemotherapy.

Methods

Human normal fibroblasts were exposed to cisplatin. The cells were then assessed for cell viability, apoptosis, production of reactive oxygen species, migratory activity, and expression of platelet‐derived growth factor receptors (PDGFRs) in the absence or presence of astaxanthin.

Results

Astaxanthin protected fibroblasts from the side effects of cisplatin, such as reduction in cell viability, apoptotic cell death, generation of reactive oxygen species, reduction in migration activity, and reduced expression of PDGFRs.

Conclusions

Our results indicate a broad range of protection from cisplatin damage in fibroblasts by astaxanthin, implying its possible use as a novel therapeutic agent against chemotherapy‐induced oral mucositis.

Zitieren

APA

Yamaguchi, M., Tomihara, K., Heshiki, W., Sakurai, K., Sekido, K., Tachinami, H., Moniruzzaman, R., Inoue, S., Fujiwara, K., & Noguchi, M. (2019). Astaxanthin ameliorates cisplatin‐induced damage in normal human fibroblasts. Oral Science International, 16(3), 171-177. https://doi.org/10.1002/osi2.1031

Vancouver

Yamaguchi M, Tomihara K, Heshiki W, Sakurai K, Sekido K, Tachinami H, et al. Astaxanthin ameliorates cisplatin‐induced damage in normal human fibroblasts. Oral Science International. 2019;16(3):171-177. doi:10.1002/osi2.1031

BibTeX
@article{Yamaguchi2019,
  author = {Yamaguchi, Momoho and Tomihara, Kei and Heshiki, Wataru and Sakurai, Kotaro and Sekido, Katsuhisa and Tachinami, Hidetake and Moniruzzaman, Rohan and Inoue, Sayaka and Fujiwara, Kumiko and Noguchi, Makoto},
  title = {Astaxanthin ameliorates cisplatin‐induced damage in normal human fibroblasts},
  journal = {Oral Science International},
  year = {2019},
  volume = {16},
  number = {3},
  pages = {171--177},
  doi = {10.1002/osi2.1031}
}
Kostenlos starten →